Alex (Aleksandrs Zavoronkovs) Zhavoronkov is the Founder, CEO, and CBO of Insilico Medicine, a clinical-stage generative AI drug discovery company. He founded and co-chairs the Aging Research and Drug Discovery (ARDD) conference, has published extensively on aging and AI including The Ageless Generation, and has held advisory roles (e.g., Haut.AI) and leadership at Deep Longevity. He holds a BCom from Queen’s University and a PhD in Physics from Lomonosov Moscow State University and is based in the Cambridge, MA area.